This inventor holds 1 USPTO granted patent. Top assignee: Eisai Company, Limited. Active years: 1991.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 1991
Title: Kiyoshi Tomioka: Innovator in Pharmaceutical Chemistry
Introduction
Kiyoshi Tomioka is a notable inventor based in Tokyo, Japan. He has made significant contributions to the field of pharmaceutical chemistry, particularly in the development of anti-tumor agents. His innovative work has led to the creation of a unique compound that holds promise for cancer treatment.
Latest Patents
Kiyoshi Tomioka holds a patent for an azacyclooctadiene compound, which is described as having the formula (1) or a pharmacologically acceptable salt thereof. This compound is recognized for its novel and useful properties as an anti-tumor agent. The detailed structure includes various functional groups that enhance its therapeutic potential.
Career Highlights
Throughout his career, Kiyoshi Tomioka has been associated with Eisai Company, Limited, where he has focused on research and development in pharmaceuticals. His work has contributed to advancements in cancer treatment, showcasing his dedication to improving patient outcomes through innovative solutions.
Collaborations
Kiyoshi has collaborated with esteemed colleagues such as Kyosuke Kitoh and Makoto Asada. These partnerships have fostered a collaborative environment that encourages the exchange of ideas and expertise in the field of pharmaceutical research.
Conclusion
Kiyoshi Tomioka's contributions to pharmaceutical chemistry, particularly through his patented azacyclooctadiene compound, highlight his role as an innovator in the fight against cancer. His work continues to inspire advancements in medical science and offers hope for future treatments.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile